CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative ...
Fondazione Telethon announces the positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommending marketing authorization in ...
The European Medicines Agency's committee has recommended approval of French drugmaker Sanofi's first-of-its-kind drug that ...
The EMA’s recommendation follows evidence that the targeted therapy improves progression-free survival in patients whose ...
NEW YORK – Fondazione Telethon said Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for its gene therapy ...
The committee reviewed data from studies showing that the antisense oligonucleotide reduced the monthly mean rate of angioedema attacks.
Shortly after crossing the FDA’s finish line, Ionis Pharmaceuticals’ RNA-targeted hereditary angioedema (HAE) treatment ...
Regulators upheld their earlier decision after reexamination, saying the substance does not meet the criteria for new active ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...
During a meeting this week, an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed 10 new ...
Anavex Life Sciences said European regulators informed it of a negative trend vote related to its application for its blarcamesine treatment of early Alzheimer's disease. The Committee for Medicinal ...
Anavex Life Sciences (AVXL) stock falls as the company faces a potential failure to win EU approval for its Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback